Onkologie. 2014:8(3):121-123

Allogeneic stem cell transplantation in treating haematological malignancies in children

Petr Sedláček, Petr Říha
Klinika dětské hematologie a onkologie
Fakultní nemocnice v Motole a 2. lékařská fakulta Univerzity Karlovy v Praze

Allogeneic haematopoietic stem cell transplantation is a therapeutic method in a wide range of malignant or non-malignant diseases.

Healthy cells of a suitable donor replace missing, malignant, or non-functional recipient's cells. The donor's immune system ensures

protection from infections while reducing the risk of disease recurrence. However, it can cause damage to the recipient's healthy tissue

(graft-versus-host disease). The sources of stem cells can include the bone marrow, stimulated peripheral blood stem cells, or umbilical-

-cord blood from a suitable related or anonymous donor from a registry.

Keywords: allogeneic transplantation, malignant disease of blood, children, search for donor, late effects of the disease

Published: June 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sedláček P, Říha P. Allogeneic stem cell transplantation in treating haematological malignancies in children. Onkologie. 2014;8(3):121-123.
Download citation

References

  1. Sramkova L, Muzikova K, Fronkova E, Krejci O, Sedlacek P, Formankova R, Mejstrikova E, Stary J, Trka J. Detectable minimal residual disease before allogeneic HSCT. Pediatr Blood Cancer 2007; 48(1): 93-100. Go to original source... Go to PubMed...
  2. Sedlacek P, Formankova R, Mejstrikova E, Keslova P, Hubacek P, Dobrovolna M, Vrana M, Kupkova L, Pittrova H, Stary J. Allogeneic stem cell transplantation in children with leukemia using HLA mismatched unrelated donors Pediatr Transplant. 2008; 12(1): 24-31. Go to original source... Go to PubMed...
  3. Krol L, Formankova R, Keslova P, Vavra V, Zemanova Z, Michalova K, Dobrovolna M, Moravcova J, Kobylka P, Ivaskova E, Navratilova J, Stary J, P Sedlacek. Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic. Neoplasma 2008; 55(2): 101-106. Go to PubMed...
  4. Sedláček P, Formánková R, Keslová P, Mejstříková E, Kobylka P, Hrubá A, Fales I, Rahmatová Š, Sieglová Z, Hubáček P, Vávra V, Šrámková L, Komrska V, Trka J, Starý J. Program transplantací kmenových buněk krvetvorby u dětí na Klinice dětské hematologie a onkologie FN Motol - od fetálních jater k pupečníkové krvi. Čes-slov Pediat 2007; 62(9): 510-518.
  5. Sedláček P, Formánková R, Keslová P, Kobylka P, Rahmatová Š, Fales I, Žižková H, Dobrovolná M, Starý J. Transplantace pupečníkovou krví - alternativa pro děti a dospělé Trans. Hemat.dnes 2008; 14(Suppl. 1): 52-56.
  6. Boelens JJ, Bierings M, Tilanus M, Lie J, Sedlacek P. Outcomes of Transplantation of Unrelated Cord Blood in Children with Malignant and Non-Malignant Diseases. An Utrecht - Prague collaborative study. Bone Marrow Transplant. 2009; 43(8) 655-657. Go to original source... Go to PubMed...
  7. Stary J, Jabali Y, Trka J, Hrusak O, Gajdos P, Hrstkova H, Sterba J, Blazek B, Hak J, Prochazkova D, Cerna Z, Smisek P, Sedlacek P, Vavra V, Mihal V, Hrodek O; Czech Pediatric Hematology working group. Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic. Leukemia. 2010; 24(2): 425-428. Go to original source... Go to PubMed...
  8. Formankova R, Sedlacek P, Keslova P, Sramkova L, Zizkova H, Stary J. Adoptive immunotherapy, chemotherapy and second allogeneic transplantation in the treatment of post-transplant relapse of acute leukemia in children - a single center experience. Leuk Lymphoma 2010; 51(10): 1936-1940. Go to original source... Go to PubMed...
  9. Strahm B, Nöllke P, Zecca M, Korthof ET, Bierings M, Furlan I, Sedlacek P, Chybicka A, Schmugge M, Bordon V, Peters C, O'Marcaigh A, de Heredia CD, Bergstraesser E, Moerloose BD, van den Heuvel-Eibrink MM, Starý J, Trebo M, Wojcik D, Niemeyer CM, Locatelli F. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia. 2011; 25(3): 455-462. Go to original source... Go to PubMed...
  10. Borgmann-Staudt A, Rendtorff R, Reinmuth S, Hohmann C, Keil T, Schuster FR, Holter W, Ehlert K, Keslova P, Lawitschka A, Jarisch A, Strauss G. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant. 2012; 47(2): 271-276. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.